Henry Schein | HSIC - Cash And Equivalent


Henry Schein reported $138M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Agilent USD 1.81B 49M Mar/2026
Align Technology USD 1.1B 42.76M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Cardinal Health USD 3.94B 1.16B Mar/2026
Charles River Laboratories USD 192.02M 195K Jun/2026
Cigna USD 6.3B 742M Jun/2026
Concord Medical Services Hldg CNY 243.38M 85.1M Jun/2023
Cooper Companies USD 124.9M 14.3M Dec/2025
CVS Health USD 11.33B 1.79B Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
Dentsply International USD 239M 49M Jun/2026
Encompass Health USD 110.5M 38.3M Mar/2026
Henry Schein USD 138M 18M Mar/2026
Idexx Laboratories USD 196.93M 3.6M Jun/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
Laboratory Of America USD 141.8M 839.3M Jun/2026
McKesson USD 5.16B 1.19B Jun/2026
Mettler Toledo International USD 51.38M 9.19M Jun/2026
Owens Minor USD 336.88M 54.89M Mar/2026
Quest Diagnostics USD 626M 233M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
Stryker USD 3.39B 513M Jun/2026
Tenet Healthcare USD 2.17B 797M Jun/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Universal Health Services USD 138.8M 19.77M Jun/2026
Veradigm USD 492.6M 7.57M Sep/2022
Waters USD 539M 77M Jun/2026
Zimmer Biomet Holdings USD 410M 14.2M Jun/2026
Zoetis USD 1.48B 465M Jun/2026